<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is caused by mutations in the gene encoding fibrillin </plain></SENT>
<SENT sid="1" pm="."><plain>A 35-year-old man with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> visited a local physician because of a sore throat </plain></SENT>
<SENT sid="2" pm="."><plain>His left tonsil gradually became swollen and he was referred to our department </plain></SENT>
<SENT sid="3" pm="."><plain>Histopathological examination of tonsil biopsy specimens showed diffuse proliferation of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells with large nuclei </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells showed CD5+, CD10+, CD20+, BCL-6+, and MUM-1- </plain></SENT>
<SENT sid="5" pm="."><plain>Based on these findings, the patient was diagnosed with CD5+ CD10+ diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>Chemotherapy combined with rituximab was administered and complete response was achieved </plain></SENT>
<SENT sid="7" pm="."><plain>CD5+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> comprises approximately 5 approximately 10% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, CD5+ CD10+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> comprises about 5% of CD5+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>There may be a relationship between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> because mutations in the gene encoding the receptor of transforming growth factor-beta (TGF-beta) have been implicated in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and downregulation of TGF-beta receptor expression has been described in the pathology of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>